Modular Medical rises after US FDA clears its insulin pump
05/09/2024 15:09
** Medical device firm Modular Medical's MODD.O shares
rise 22% to $2.39
** Company said on Wednesday that U.S. FDA had cleared its
MODD1 insulin pump for adults with type 1 and type 2 diabetes
** Modular expects device to be available for sale in early
2025
** Including session gains, stock up ~32% YTD
(Reporting by Kashish Tandon in Bengaluru)
((kashish.tandon@thomsonreuters.com))